{"public_id":"cl_1c3fbb811b425d09f09af0cee5bc4fce","status":"active","superseded_by_public_id":null,"corpus_id":19188517,"text":"Sustained normalization of serum alanine aminotransferase concentrations and histologic improvement were highly correlated with virologic response.","confidence":0.85,"paper":{"corpus_id":19188517,"title":"Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.","url":"https://sah.borca.ai/papers/19188517"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_49c6f267b700735aac9b372c6daf4492","name":"virologic response","description":"The reduction to undetectable levels of hepatitis C virus RNA in serum, used as the primary efficacy endpoint of treatment.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_49c6f267b700735aac9b372c6daf4492"},{"public_id":"co_6da359cc4a9ee6e3120d2672c63195bc","name":"histologic improvement","description":"A measured improvement in liver tissue pathology used as an outcome indicator in this trial.","types":["outcome measure"],"url":"https://sah.borca.ai/concepts/co_6da359cc4a9ee6e3120d2672c63195bc"},{"public_id":"co_d9eb3a36c7871425c00ca8325c41a5b7","name":"serum alanine aminotransferase","description":"A liver enzyme measured in blood serum as an indicator of biochemical response to treatment.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_d9eb3a36c7871425c00ca8325c41a5b7"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_1c3fbb811b425d09f09af0cee5bc4fce"}